End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.825 PLN | -0.60% | -0.60% | +42.24% |
09/02 | Dr.Finance S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/02 | Dr.Finance S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2017 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Capitalization 1 | 2.02 | 1.189 | 6.096 | 4.469 |
Enterprise Value (EV) 1 | 2.176 | 0.6865 | 5.535 | 3.835 |
P/E ratio | 4.19 x | 6.34 x | -450 x | 29.9 x |
Yield | - | - | - | - |
Capitalization / Revenue | 0.35 x | 0.17 x | 0.79 x | 0.38 x |
EV / Revenue | 0.38 x | 0.1 x | 0.72 x | 0.33 x |
EV / EBITDA | 5.55 x | 2.62 x | 598 x | 19 x |
EV / FCF | -16 x | 2.63 x | 125 x | 87.1 x |
FCF Yield | -6.23% | 38.1% | 0.8% | 1.15% |
Price to Book | 19.8 x | 1.87 x | 9.37 x | 5.59 x |
Nbr of stocks (in thousands) | 3,740 | 3,740 | 3,740 | 3,740 |
Reference price 2 | 0.5400 | 0.3180 | 1.630 | 1.195 |
Announcement Date | 01/06/18 | 31/05/21 | 31/05/21 | 31/05/22 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales 1 | 5.751 | 7.181 | 7.722 | 11.74 |
EBITDA 1 | 0.3919 | 0.2618 | 0.009263 | 0.2018 |
EBIT 1 | 0.2173 | 0.1884 | 0.001866 | 0.1944 |
Operating Margin | 3.78% | 2.62% | 0.02% | 1.66% |
Earnings before Tax (EBT) 1 | 0.4822 | 0.1876 | -0.006542 | 0.1978 |
Net income 1 | 0.4822 | 0.1876 | -0.0135 | 0.1492 |
Net margin | 8.38% | 2.61% | -0.18% | 1.27% |
EPS 2 | 0.1289 | 0.0502 | -0.003619 | 0.0399 |
Free Cash Flow 1 | -0.1356 | 0.2612 | 0.0444 | 0.044 |
FCF margin | -2.36% | 3.64% | 0.57% | 0.38% |
FCF Conversion (EBITDA) | - | 99.8% | 479.06% | 21.83% |
FCF Conversion (Net income) | - | 139.26% | - | 29.52% |
Dividend per Share | - | - | - | - |
Announcement Date | 01/06/18 | 31/05/21 | 31/05/21 | 31/05/22 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net Debt 1 | 0.16 | - | - | - |
Net Cash position 1 | - | 0.5 | 0.56 | 0.63 |
Leverage (Debt/EBITDA) | 0.3993 x | - | - | - |
Free Cash Flow 1 | -0.14 | 0.26 | 0.04 | 0.04 |
ROE (net income / shareholders' equity) | 1,001% | 34.6% | -2.1% | 20.6% |
ROA (Net income/ Total Assets) | 8.22% | 16.9% | 0.13% | 10.2% |
Assets 1 | 5.867 | 1.108 | -10.25 | 1.46 |
Book Value Per Share 2 | 0.0300 | 0.1700 | 0.1700 | 0.2100 |
Cash Flow per Share 2 | 0.1300 | 0.1300 | 0.1500 | 0.1700 |
Capex 1 | 0 | 0.02 | 0.01 | - |
Capex / Sales | 0.05% | 0.25% | 0.11% | - |
Announcement Date | 01/06/18 | 31/05/21 | 31/05/21 | 31/05/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+42.24% | 792K | |
-1.50% | 120B | |
+5.79% | 97.54B | |
+14.19% | 69.04B | |
+21.20% | 65.26B | |
+13.29% | 44.18B | |
+15.31% | 43.11B | |
+19.70% | 36.3B | |
+9.28% | 26.27B | |
-1.25% | 23.22B |
- Stock Market
- Equities
- DRF Stock
- Financials Dr.Finance S.A.